Preliminary analysis of mortality associated with rituximab use in autoimmune diseases.
about
Treatment Options for Primary Autoimmune Hemolytic Anemia: A Short Comprehensive ReviewNon-ischemic cardiomyopathy after rituximab treatment for membranous nephropathy.Anti-B-Cell Therapies in Autoimmune Neurological Diseases: Rationale and Efficacy Trials.Autoimmunity in 2013.Efficacy and safety of rituximab therapy in patients with pemphigus vulgaris: first report from Turkey.Immunosuppressive therapy for eye diseases: Effectiveness, safety, side effects and their prevention.Intraorbital injection of rituximab versus high dose of systemic glucocorticoids in the treatment of thyroid-associated orbitopathy.Rapid response to and long-term effectiveness of anti-CD20 antibody in conventional therapy resistant Graves' orbitopathy: A five-year follow-up study.
P2860
Q26773178-5758BFFF-1CAF-41BB-86D1-6F7D0D331F66Q33630988-9FA5C90F-6F7F-44C9-853B-273A49EA2425Q36484465-699F3384-AA0B-4D87-BADC-F10648C30362Q38211189-C9A8AA28-AEBC-4AED-9BCD-AC56A1E3627DQ39366479-5198A87E-0641-4282-AF2E-A10DDB145E6DQ42359937-7AC4177E-8B50-4F57-9A1C-081829E53D1EQ44766839-9182BC3E-EB90-4DA5-9BED-6ED44DAEB3A9Q53059480-A64128D3-1922-41C3-A224-C7E2FF76B950
P2860
Preliminary analysis of mortality associated with rituximab use in autoimmune diseases.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Preliminary analysis of mortality associated with rituximab use in autoimmune diseases.
@en
type
label
Preliminary analysis of mortality associated with rituximab use in autoimmune diseases.
@en
prefLabel
Preliminary analysis of mortality associated with rituximab use in autoimmune diseases.
@en
P2860
P1433
P1476
Preliminary analysis of mortality associated with rituximab use in autoimmune diseases.
@en
P2093
Shawn Shetty
P2860
P304
P356
10.3109/08916934.2013.838563
P577
2013-10-24T00:00:00Z